WorldPingZambia signs US health deal after disputes over data-sharing
The US will provide $1.5bn (£1.1bn) under the deal that was negotiated after Trump cut USAID funding.
Brief by WorldPing · Original reporting by BBC News
The administration signed a $1.5 billion agreement with Zambia, but only after being forced to abandon controversial data-sharing and resource-access provisions.
International stories like this one shape diplomacy, travel, energy supply and security decisions well beyond the country involved, which is why WorldPing tracks every update on it in one place.
When each newsroom published on this story, oldest first — all times UTC.
Zambia signs US health deal after disputes over data-sharing
U.S. backtracked on critical mineral, data demands in health deal with Zambia
The original report was published by Washington Post. WorldPing does not claim that reporting — this page summarises and contextualises it.
Read the full report at Washington PostLiving hubs that keep updating as this story develops.
WorldPingThe US will provide $1.5bn (£1.1bn) under the deal that was negotiated after Trump cut USAID funding.
Brief by WorldPing · Original reporting by BBC News
WorldPingResearch published in the International Journal of Business Innovation and Research (IJBIR) suggests that African economies need to move beyond fragmented development strategies.
Brief by WorldPing · Original reporting by Phys.org
Health Secretary Robert F. Kennedy Jr. has established a new clinic at the National Institutes of Health to study vaccine injuries. It's part of a larger administration effort on vaccine safety.
Brief by WorldPing · Original reporting by NPR Health
WorldPingFor several decades, Norwegian prison research has focused on the pains of imprisonment, isolation and the harm that prison does. But what is needed for a prison to actually promote health, personal growth and hope?
Brief by WorldPing · Original reporting by Phys.org
WorldPing“It’s far easier to blame AI than it is to blame health care costs,” the billionaire and founder of Cost Plus Drugs said. The math makes his point.
Brief by WorldPing · Original reporting by Fortune